Boron neutron capture therapy for glioblastoma multiforme: Enhanced drug delivery and antitumor effect following blood-brain barrier disruption induced by focused ultrasound

Future Oncology

Volumn 8, Issue 10, 2012, Pages 1361-1369

  Yang, Feng Yi ^a   Chen, Yi Wei ^b   Chou, Fong In ^c   Yen, Sang Hue ^a,b   Lin, Yi Li ^a   Wong, Tai Tong ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

blood brain barrier disruption; boron neutron capture therapy; boronophenylalanine; brain tumor; focused ultrasound

Indexed keywords

4 BORONOPHENYLALANINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; CELL GROWTH; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; ECHOGRAPHY; FOCUSED ULTRASOUND; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MOUSE; NEUTRON CAPTURE THERAPY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BLOOD-BRAIN BARRIER; BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; DRUG DELIVERY SYSTEMS; GLIOBLASTOMA; HUMANS; PHENYLALANINE; RATS; SOUND; TISSUE DISTRIBUTION;

EID: 84868586326     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.12.118     Document Type: Article

References (31)

1. Black KL, Ningaraj NS. Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor. Cancer Control 11(3), 165-173 (2004 (Pubitemid 38758221)
2. Deen DF, Chiarodo A, Grimm EA et al. Brain Tumor Working Group Report on the 9th International Conference on Brain Tumor Research and Therapy. Organ System Program, National Cancer Institute. J. Neurooncol. 16(3), 243-272 (1993 (Pubitemid 23335753)
3. Barth RF. A critical assessment of boron neutron capture therapy: An overview. J. Neurooncol. 62(1-2), 1-5 (2003 (Pubitemid 36553113)
4. Barth RF, Soloway AH, Brugger RM. Boron neutron capture therapy of brain tumors: Past history, current status, and future potential. Cancer Invest. 14(6), 534-550 (1996 (Pubitemid 26423516)
5. Barth RF, Coderre JA, Vicente MG, Blue TE. Boron neutron capture therapy of cancer: Current status and future prospects. Clin. Cancer Res. 11(11), 3987-4002 (2005 (Pubitemid 40791562)
6. Barth R, Yang W, Rotaru J et al. Boron neutron capture therapy of brain tumors: Enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine. Int. J. Radiat. Oncol. Biol. Phys 47(1), 209-218 (2000 (Pubitemid 30179697)
7. Barth R, Yang W, Rotaru J et al. Boron neutron capture therapy of brain tumors: Enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption. Cancer Res. 57(6), 1129-1136 (1997 (Pubitemid 27138613)
8. Barth RF, Yang W, Bartus RT et al. Neutron capture therapy of intracerebral melanoma: Enhanced survival and cure after blood-brain barrier opening to improve delivery of boronophenylalanine. Int. J. Radiat. Oncol. Biol. Phys 52(3), 858-868 (2002 (Pubitemid 34158752)
9. Hsieh CH, Chen YF, Chen FD et al. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-l-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption. J. Nucl. Med. 46(11), 1858-1865 (2005
10. Yang FY, Horng SC, Lin YS, Kao YH. Association between contrast-enhanced MR images and blood-brain barrier disruption following transcranial focused ultrasound. J. Magn. Reson. Imaging 32(3), 593-599 (2010
11. Yang FY, Lin YS, Kang KH, Chao TK. Reversible blood-brain barrier disruption by repeated transcranial focused ultrasound allows enhanced extravasation. J. Control. Release 150(1), 111-116 (2011
12. Yang FY, Liu SH, Ho FM, Chang CH. Effect of ultrasound contrast agent dose on the duration of focused-ultrasound-induced blood-brain barrier disruption. J. Acoust. Soc. Am. 126(6), 3344-3349 (2009
13. Yang FY, Lin GL, Horng SC et al. Pulsed high-intensity focused ultrasound enhances the relative permeability of the blood-tumor barrier in a glioma-bearing rat model. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 58(5), 964-970 (2011
14. Yang FY, Wang HE, Lin GL et al. Micro- SPECT/CT-based pharmacokinetic analysis of 99mTc-diethylenetriaminepentaacetic acid in rats with blood-brain barrier disruption induced by focused ultrasound. J. Nucl. Med. 52(3), 478-484 (2011
15. Lee WH, Yeh MY, Tu YC, Han SH, Wang YC. Establishment and characterization of a malignant glioma cell line, GBM8401/ TSGH,NDMC. J. Surg. Oncol. 38(3), 173-181 (1988
16. Yang FY, Teng MC, Lu M et al. Treating glioblastoma multiforme with selective high-dose liposomal doxorubicin chemotherapy induced by repeated focused ultrasound. Int. J. Nanomed. 7, 965-974 (2012
17. Yang FY, Wong TT, Teng MC et al. Focused ultrasound and interleukin-4 receptortargeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme. J. Control. Release 160(3), 652-658 (2012
18. Yang W, Barth RF, Carpenter DE, Moeschberger ML, Goodman JH. Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption. Neurosurgery 38(5), 985-992 (1996 (Pubitemid 26127584)
19. Neuwelt EA, Barnett PA, Bigner DD, Frenkel EP. Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: The factor of the blood-brain barrier. Proc. Natl Acad. Sci. USA 79(14), 4420-4423 (1982 (Pubitemid 12045805)
20. Abbott NJ, Romero IA. Transporting therapeutics across the blood-brain barrier. Mol. Med. Today 2(3), 106-113 (1996 (Pubitemid 126407728)
21. Nag S. Morphology and molecular properties of cellular components of normal cerebral vessels. Methods Mol. Med. 89, 3-36 (2003
22. Pardridge WM. Drug and gene delivery to the brain: The vascular route. Neuron 36(4), 555-558 (2002 (Pubitemid 35346750)
23. Kawabata S, Yang W, Barth RF et al. Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors. J. Neurooncol. 103(2), 175-185 (2011
24. Tomiwa K, Hazama F, Mikawa H. Neurotoxicity of vincristine after the osmotic opening of the blood-brain barrier. Neuropathol. Appl. Neurobiol. 9(5), 345-354 (1983 (Pubitemid 13016923)
25. Neuwelt EA, Hill SA, Frenkel EP. Osmotic blood-brain barrier modification and combination chemotherapy: Concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening. Neurosurgery 15(3), 362-366 (1984 (Pubitemid 14029951)
26. Bekeredjian R, Kroll R, Fein E et al. Ultrasound targeted microbubble destruction increases capillary permeability in hepatomas. Ultrasound Med. Biol. 33(10), 1592-1598 (2007 (Pubitemid 47444492)
27. Yang FY, Lee PY. Efficiency of drug delivery enhanced by acoustic pressure during blood-brain barrier disruption induced by focused ultrasound. Int. J. Nanomed. 7, 2573-2582 (2012
28. Skold K, H-Stenstam B, Diaz AZ, Giusti V, Pellettieri L, Hopewell JW. Boron neutron capture therapy for glioblastoma multiforme: Advantage of prolonged infusion of BPA-f. Acta Neurol. Scand. 122(1), 58-62 (2010
29. Yuh EL, Shulman SG, Mehta SA et al. Delivery of systemic chemotherapeutic agent to tumors by using focused ultrasound: Study in a murine model. Radiology 234(2), 431-437 (2005 (Pubitemid 40139913)
30. Frenkel V, Kimmel E, Iger Y. Ultrasoundinduced intercellular space widening in fish epidermis. Ultrasound Med. Biol. 26(3), 473-480 (2000 (Pubitemid 30204561)
31. Barth RF, Adams DM, Soloway AH, Alam F, Darby MV. Boronated starburst dendrimermonoclonal antibody immunoconjugates: Evaluation as a potential delivery system for neutron capture therapy. Bioconjug. Chem. 5(1), 58-66 (1994 (Pubitemid 2043885)